Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy - A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

被引:880
作者
Nathan, David M. [1 ]
Buse, John B.
Davidson, Mayer B.
Heine, Robert J.
Holman, Rury R.
Sherwin, Robert
Zinman, Bernard
机构
[1] Massachusetts Gen Hosp, Diabet Ctr, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Univ N Carolina, Sch Med, Chapel Hill, NC USA
[4] Charles R Drew Univ, Clin Trials Unit, Los Angeles, CA USA
[5] Vrije Univ Amsterdam, Ctr Med, Diabet Ctr, Amsterdam, Netherlands
[6] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Diabet Trials Unit, Oxford, England
[7] Yale Univ, Sch Med, Dept Internal Med & Endocrinol, New Haven, CT USA
[8] Univ Toronto, Mt Sinai Hosp, Dept Endocrinol & Metab, Toronto, ON, Canada
关键词
D O I
10.2337/dc06-9912
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1963 / 1972
页数:10
相关论文
共 76 条
[1]   VETERANS AFFAIRS COOPERATIVE STUDY ON GLYCEMIC CONTROL AND COMPLICATIONS IN TYPE-II DIABETES (VA CSDM) - RESULTS OF THE FEASIBILITY TRIAL [J].
ABRAIRA, C ;
COLWELL, JA ;
NUTTALL, FQ ;
SAWIN, CT ;
NAGEL, NJ ;
COMSTOCK, JP ;
EMANUELE, NV ;
LEVIN, SR ;
HENDERSON, W ;
LEE, HS .
DIABETES CARE, 1995, 18 (08) :1113-1123
[2]  
*AM DIAB ASS, 2005, DIABETES CARE S1, V28, pS15
[3]  
Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4
[4]  
[Anonymous], 1999, Diabet Med, V16, P716
[5]  
[Anonymous], 1995, DIABETES, V44, P968
[6]   Rosiglitazone/metformin fixed-dose combination compared with uptitrated metformin alone in type 2 diabetes mellitus: A 24-week, multicenter, randomized, double-blind, parallel-group study [J].
Bailey, CJ ;
Bagdonas, A ;
Rubes, J ;
McMorn, SO ;
Donaldson, J ;
Biswas, N ;
Stewart, MW .
CLINICAL THERAPEUTICS, 2005, 27 (10) :1548-1561
[7]   Drug therapy - Metformin [J].
Bailey, CJ ;
Turner, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (09) :574-579
[8]  
BASTIEN A, 2004, PRACT DIABETOL, V23, P6
[9]   Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes [J].
Buse, JB ;
Henry, RR ;
Han, J ;
Kim, DD ;
Fineman, MS ;
Baron, AD .
DIABETES CARE, 2004, 27 (11) :2628-2635
[10]   Inhaled human insulin treatment in patients with type 2 diabetes mellitus [J].
Cefalu, WT ;
Skyler, JS ;
Kourides, IA ;
Landschulz, WH ;
Balagtas, CC ;
Cheng, SL ;
Gelfand, RA .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (03) :203-207